IRCT20180819040830N2CompletedPhase 3
Efficacy and Safety of Prophylactic Use of Tranexamic Acid for Decreasing the Blood Loss in Elective Cesarean Section: A Placebo-Controlled Randomized Clinical Trial
Conditions
Trial Snapshot
- Phase
- Phase 3
- Status
- Completed
- Enrollment
- 200
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 18 years to no limit (—)
- Sex
- Female
Inclusion Criteria
- •singleton pregnant women
- •elective cesarean section
- •gestational age between 37 and 42 weeks
Exclusion Criteria
- •patients with Known allergy to TXA
- •history of thromboembolic or coagulation disorders
- •known history of renal, cardiac or hepatic impairment
- •gestational or chronic hypertension/pre-eclampsia
- •placental disorders
- •polyhydramnios
- •patients who had received aspirin 1 week before surgery
Investigators
Similar Trials
Completed
Phase 3
anesthesia technique in jaw surgeriesDentofacial anomaly, unspecified.Dentofacial anomaly, unspecifiedIRCT2014060115963N2Guilan University of Medical Sciences Research Vice90
Completed
Phase 3
Prophylactic effect of tranexamic acid capsule in controlling epistaxisEpistaxis.EpistaxisR04.0IRCT20180425039418N7Zahedan University of Medical Sciences100
Not yet recruiting
Phase 4
To compare the effectiveness of oral tablets of tranexamic acid and vitamin C versus injections of tranexamic acid and vitamin C over face in patients with melasmaCTRI/2024/01/061709Dr RPGMC Tanda
Completed
Not Applicable
Evaluation of the prophylactic effect of tranexamic acid in von willebrand disease and glanzman thrombastheniaCondition 1: Glanzmann thrombasthenia. Condition 2: Von Willebrand.Qualitative platelet defectsVon Willebrand diseaseIRCT2015111525031N2Vice Chancellor for research of Arak University of Medical Sciences20
Not yet recruiting
Phase 2
Tranexamic acid in chronic urticariachronic urticaria.Other urticariaL50.8IRCT20220205053947N1Shiraz University of Medical Sciences80